Corrigendum: Biocontainment of genetically modified organisms by synthetic protein design

Nature 518, 55–60 (2015); doi:10.1038/nature14121 In the interests of transparency, we wish to amend the competing financial interests of this Article to read: “Harvard has filed a provisional patent application. G.M.C. is a founder of Enevolv Inc. and Gen9bio. Other potentially relevant financial interests are listed at http://arep.